Name | Pantoprazole |
Synonyms | Pantoprazole PANTOPRAZOLE 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1h-benzimidazole 5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-3H-benzoimidazole 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-yridinyl)methyl]sulfinyl]-1h-benzimidazole 5-(DIFLUOROMETHOXY)-2-[[(3,4-DIMETHOXY-2-PYRIDINYL)METHYL]SULFINYL]-1H-BENZIMIDAZOLE 5-Difluoromethoxy-2-{[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl }-1H-benzimidazole 6-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole |
CAS | 102625-70-7 |
EINECS | 600-331-6 |
InChI | InChI=1/C16H15F2N3O4S/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21) |
Molecular Formula | C16H15F2N3O4S |
Molar Mass | 383.37 |
Density | 1.51±0.1 g/cm3(Predicted) |
Melting Point | 139-140° (dec) |
Boling Point | 586.9±60.0 °C(Predicted) |
Flash Point | 308.7°C |
Solubility | Chloroform (Slightly), Methanol (Slightly, Heated, Sonicated) |
Vapor Presure | 9.37E-14mmHg at 25°C |
Appearance | Solid |
Color | Off-White to Pale Orange |
pKa | pKa1 3.92; pKa2 8.19(at 25℃) |
Storage Condition | Inert atmosphere,Store in freezer, under -20°C |
Refractive Index | 1.642 |
Physical and Chemical Properties | Off-white solid, melting point 139-140 °c (decomposition). PKA 3.92; PKA 28.19. Pantoprazole sodium: C16H14F2N3NaO4S. [138786-67-1]. White to off-white solid, melting point> 130 °c (decomposition). UV absorption maximum (methanol):289nm (φ16400). |
Use | For the treatment of active peptic ulcer reflux esophagitis and Zollinger-Ellison syndrome |
Hazard Symbols | Xn - Harmful |
Risk Codes | R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. R37/38 - Irritating to respiratory system and skin. R41 - Risk of serious damage to eyes R48 - Danger of serious damage to health by prolonged exposure |
Safety Description | S22 - Do not breathe dust. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
off-white solid, melting point 139-140 °c.
2-thiol -5-= fluoromethoxy -1H-benzimidazole and 2-chloromethyl -3,4-= methoxypyridine hydrochloride condensation, the product is then oxidized with M-chloroperbenzoic acid, pantoprazole was obtained.
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.608 ml | 13.042 ml | 26.084 ml |
5 mM | 0.522 ml | 2.608 ml | 5.217 ml |
10 mM | 0.261 ml | 1.304 ml | 2.608 ml |
5 mM | 0.052 ml | 0.261 ml | 0.522 ml |
developed by Byk GuLDen in Germany, first launched in Germany in 1994. Anti-ulcer drugs. Pantoprazole is an irreversible proton pump inhibitor that can be activated to sulfenamide in the acidic environment of gastric parietal cells, and then specifically with the final link of gastric acid secretion-Proton Pump (I. E. HtK ATP alcohol) on the thiol by covalent bond, so that the loss of acid secretion function. It is used for duodenal ulcer, gastric ulcer, reflux esophagitis and Zollinger's syndrome, especially for ulcer with bleeding, Vomit or unable to eat, refractory ulcer and acute pancreatitis. It can also be used to prevent stress ulcer caused by major surgery or severe trauma.